COR THERAPEUTICS INC / DE
10-Q, EX-27.1, 2000-08-10
PHARMACEUTICAL PREPARATIONS
Previous: COR THERAPEUTICS INC / DE, 10-Q, EX-10.1, 2000-08-10
Next: CORVEL CORP, 10-Q, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED BALANCE SHEETS, CONDENSED STATEMENTS OF OPERATIONS, AND CONDENSED
STATEMENTS OF CASH FLOWS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD
ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS AND THE NOTES THERETO.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          65,634
<SECURITIES>                                   277,244
<RECEIVABLES>                                    8,485
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               384,799
<PP&E>                                          25,994
<DEPRECIATION>                                (21,739)
<TOTAL-ASSETS>                                 399,293
<CURRENT-LIABILITIES>                           58,783
<BONDS>                                        300,000
                                0
                                          0
<COMMON>                                             3
<OTHER-SE>                                      38,233
<TOTAL-LIABILITY-AND-EQUITY>                   399,293
<SALES>                                              0
<TOTAL-REVENUES>                                42,978
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                61,420
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               5,915
<INCOME-PRETAX>                               (16,438)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (16,438)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (16,438)
<EPS-BASIC>                                    (.63)<F1>
<EPS-DILUTED>                                    (.63)
<FN>
<F1>For Purposes of this Exhibit, Primary means Basic.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission